REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
01/24/2026
Back to search
Official data from USPTO
D DOMPÉ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
01/25/2026
Trademark type
Combined
Nice classes
5, 41, 42
Filing date
12/29/2014
Registration date
01/24/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
01/25/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
Milano, IT
Examiner
THOMAS, JULIE
Law office
L70
Mark description
The mark consists of a black-outlined, red hexagon with a white letter "D" in the center and the wording "DOMPÉ" in black to the right of the design.
Holders and representatives
Holders
DOMPE' FARMACEUTICI S.P.A.
DOMPE' FARMACEUTICI S.P.A.
Representatives
Kristen McCallion Fish & Richardson P.C.
Technical classification
Nice Classes
Class 5Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use ; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparationsanticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseasesanti-infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparationsan analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants
Class 41
Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education serviceproviding tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests
Class 42
Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmologytreatment of cancerdiabetesanalgesic preparationsnerve grow factorsoncologyorgan transplantationantibioticsrespiratory diseasesbone diseasesrare diseases; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingmedical diagnosticsdrug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancerdiabetesrespiratory diseasesbone diseasesrare diseasesocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields
Publications
History of USPTO decisions and trademark events.
47 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/13/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
02/01/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/08/2025
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/18/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
12/18/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/03/2024
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
12/02/2024
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
04/02/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
04/02/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/01/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
07/24/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/24/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/04/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/13/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/25/2017
FIMP
FINAL DISPOSITION PROCESSED
04/25/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/24/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
01/24/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/18/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/08/2016
PUBO
PUBLISHED FOR OPPOSITION
11/08/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/19/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/19/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/28/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/28/2016
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/28/2016
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/30/2016
GNFR
FINAL REFUSAL E-MAILED
06/30/2016
CNFR
FINAL REFUSAL WRITTEN
06/30/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/28/2016
RFNT
REFUSAL PROCESSED BY IB
12/18/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2015
RFRR
REFUSAL PROCESSED BY MPU
12/01/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/26/2015
CNRT
NON-FINAL ACTION WRITTEN
11/25/2015
MAFR
APPLICATION FILING RECEIPT MAILED
11/14/2015
DOCK
ASSIGNED TO EXAMINER
11/10/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/09/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/07/2015
Continuous trademark protection
Get notified about every new filing that threatens D DOMPÉ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.